Supplemental material
Annals of Medicine
Volume 54, 2022 - Issue 1
Open access
2,090
Views
2
CrossRef citations to date
0
Altmetric
Hematology
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors
Yuriko Nishiyama-Fujitaa Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan
https://orcid.org/0000-0003-3338-0938View further author information
Tomonori Nakazatoa Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-3579-4018View further author information
Noriyoshi Iriyamab Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, JapanView further author information
, Michihide Tokuhirac Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
, Maho Ishikawad Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, JapanView further author information
, Eriko Satoe Department of Hematology, Juntendo University Nerima Hospital, Tokyo, JapanView further author information
, Tomoiku Takakuf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
, Keiji Sugimotog Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, JapanView further author information
, Hiroyuki Fujitah Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, JapanView further author information
, Isao Fujiokaf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
, Shun Tsuchiyaf Department of Hematology, Juntendo University School of Medicine, Tokyo, JapanView further author information
, Yuta Kimurac Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
, Eisaku Iwanagai Department of Hematology, Kumamoto University Hospital, Kumamoto, JapanView further author information
, Norio Komatsuf Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
https://orcid.org/0000-0003-1880-9126View further author information
Norio Asoud Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Saitama, JapanView further author information
, Masahiro Kizakic Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, JapanView further author information
, Yoshihiro Hattab Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, JapanView further author information
& Tatsuya Kawaguchij Medical Technology, Kumamoto Health Science University, Kumamoto, JapanView further author information
show all
Pages 1244-1254
|
Received 19 Oct 2021, Accepted 18 Apr 2022, Published online: 29 Apr 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.